Zuga Matt

CIK 00017902144 companiesNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001790214

Recent Transactions

50 trades

Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-07$1.99/sh−1,700→ 216,839 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-07$2.00/sh−4,105→ 218,539 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-06$1.97/sh−5,100→ 222,644 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-05$1.96/sh−4,000→ 227,744 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2025-05-29+60,339→ 60,339 total
Purchase
ELUTIA INC.$ELUT
Class A Common Stock
2025-02-03$2.50/sh+420,000→ 9,520,232 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-23$1.72/sh−28,902→ 231,744 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-21$1.60/sh−4,364→ 260,646 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-06+66,800→ 265,010 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2025-01-06+100,300→ 100,300 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-03$1.84/sh−13,235→ 198,210 total
Exercise of In-Money
ELUTIA INC.$ELUT
Warrants (right to buy)
2024-07-30−2,101,577→ 0 total
Exercise of In-Money
ELUTIA INC.$ELUT
Class A Common Stock
2024-07-30$1.43/sh+2,101,577→ 9,100,232 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2024-06-06+31,835→ 31,835 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2024-01-18$3.71/sh−4,242→ 211,445 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2024-01-02+106,000→ 215,687 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2024-01-02+159,000→ 159,000 total
Other
ELUTIA INC.$ELUT
Warrants (right to buy)
2023-12-28−2,154,116→ 2,101,577 total
Other
ELUTIA INC.$ELUT
Class A Common Stock
2023-12-28−1,436,077→ 6,998,655 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2023-06-08+37,500→ 37,500 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2023-06-08+25,000→ 25,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2023-01-17+150,800→ 150,800 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2023-01-17+33,500→ 109,687 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2022-12-29−50,000→ 401,369 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2022-12-29$1.19/sh+50,000→ 76,187 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2022-12-22+17,533→ 17,533 total
Purchase
ELUTIA INC.$ELUT
Class A Common Stock
2022-12-05$4.75/sh+735,000→ 5,597,604 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2022-06-07+22,090→ 22,090 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2022-06-07+22,090→ 22,090 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2022-01-19+150,000→ 150,000 total
Purchase
ELUTIA INC.$ELUT
Class A Common Stock
2021-12-08$4.24/sh+58,962→ 90,807 total
Purchase
ELUTIA INC.$ELUT
Class A Common Stock
2021-12-08$4.24/sh+353,773→ 4,862,604 total
Purchase
ELUTIA INC.$ELUT
Warrants (right to buy)
2021-09-21+4,255,693→ 4,255,693 total
Purchase
ELUTIA INC.$ELUT
Class A Common Stock
2021-09-21+2,837,128→ 8,434,732 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Series A-1 Preferred Stock
2021-07-06−15,659→ 15,659 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-07-06+26,187→ 26,187 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Series B Preferred Stock
2021-07-06−10,528→ 10,528 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2021-06-07+14,082→ 14,082 total
Award
ELUTIA INC.$ELUT
Stock Option (Right to Buy)
2021-06-07+14,082→ 14,082 total
Exercise of In-Money
ELUTIA INC.$ELUT
Warrant
2020-10-13−7,655→ 0 total
Purchase
ELUTIA INC.$ELUT
Class A Common Stock
2020-10-13$17.00/sh+441,176→ 4,508,831 total
Tax Payment
ELUTIA INC.$ELUT
Class A Common Stock
2020-10-13$5.44/sh−2,451→ 4,067,655 total
Conversion
ELUTIA INC.$ELUT
Class A Common Stock
2020-10-13+4,062,451→ 4,062,451 total
Conversion
ELUTIA INC.$ELUT
Series A Convertible Preferred Stock
2020-10-13−31,133,977→ 0 total
Exercise of In-Money
ELUTIA INC.$ELUT
Class A Common Stock
2020-10-13$5.44/sh+7,655→ 4,070,106 total
Conversion
TELA Bio, Inc.$TELA
Common Stock
2019-11-13+217,816→ 498,606 total
Conversion
TELA Bio, Inc.$TELA
Series B Preferred Stock
2019-11-13−5,377,928→ 0 total
Conversion
TELA Bio, Inc.$TELA
Series A Preferred Stock
2019-11-13−493,357→ 0 total
Conversion
TELA Bio, Inc.$TELA
Common Stock
2019-11-13+19,982→ 280,790 total
Conversion
TELA Bio, Inc.$TELA
Series A Preferred Stock
2019-11-13−6,643→ 0 total

Companies

Recent Filings

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465

View on SEC.gov